# US 2026/0076591 A1 · Systems and methods for diabetes management

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076591 A1
- Document ID: US20260076591A1
- Status: Published application
- Kind: A1
- Application number: 19/110,942
- Filed: 2023-09-12
- Published: 2026-03-19
- Earliest claimed: 2022-09-14
- Assignees: Abbott Diabetes Care Inc.
- Applicants: Abbott Diabetes Care Inc.
- Inventors: Panganamala Ashwin Kumar; Taylor M. Charlesworth; Andrew M. Revoltar; Saranpreet S. Nagra
- Web page: https://patentgrep.com/patent/US20260076591A1

## CPC

- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- G16H 20/17: delivered via infusion or injection
- A61B 5/4839: {combined with drug delivery}
- A61B 5/743: {Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots}
- G06F 9/453: {Help systems}
- G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof
- A61B 5/0004: {characterised by the type of physiological signal transmitted}
- A61B 2560/0276: Determining malfunction
- G16H 40/63: for local operation
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)

## Abstract

Systems, devices and methods are provided for incorporating a medication delivery device into an integrated management system. The integrated management system may be an integrated diabetes management system and may include a glucose monitor, a connected insulin pen, and software. The integrated management system may produce a plurality of reports that may include data related to analyte levels (e.g., glucose levels) and medication delivered (e.g., insulin delivered). The integrated system may also include a mode in which certain types of data are no longer shared and/or stored if the user is not signed into an account. The types of data shared and/or stored when the user is not signed into an account may differ from the types of data shared and/or stored when the user is signed into an account.

## Claims

### Claim 1

An analyte monitoring system, comprising:
a reader device, comprising:
a display;
wireless communication circuitry configured to receive, from an on-body unit comprising an analyte sensor, a first type of data, and to receive, from a medication delivery device, a second type of data,
wherein the first type of data comprises data indicative of an analyte level of the subject, and
wherein the second type of data comprises error data associated with the medication delivery device; and
one or more processors coupled to a memory, the memory storing instructions that, when executed by the one or more processors, cause the one or more processors to:
display information associated with the data indicative of the analyte level of the subject; and
display a message based on the received error data.

### Claim 2 (depends on 1)

The analyte monitoring system of claim 1, wherein the message is displayed in a modal window.

### Claim 3 (depends on 1)

The analyte monitoring system of claim 1, wherein the message is displayed in a banner.

### Claim 4 (depends on 1)

The analyte monitoring system of claim 1, wherein the error data comprises data indicative of a number of failed scans of the medication delivery device.

### Claim 5 (depends on 4)

The analyte monitoring system of claim 4, wherein the message is displayed if the number of failed scans exceeds a threshold value.

### Claim 6 (depends on 5)

The analyte monitoring system of claim 5, wherein the message comprises a tip related to scanning the medication delivery device.

### Claim 7 (depends on 5)

The analyte monitoring system of claim 5, wherein the message comprises an animation depicting how to scan the medication delivery device.

### Claim at position 8

8-12. (canceled)

### Claim 13

An analyte monitoring system, comprising:
a reader device, comprising:
a display;
wireless communication circuitry configured to receive, from an on-body unit comprising an analyte sensor, a first type of data, and to receive, from a medication delivery device, a second type of data,
wherein the first type of data comprises data indicative of an analyte level of the subject, and
wherein the second type of data comprises medication dosing data; and
one or more processors coupled to a memory, the memory storing instructions that, when executed by the one or more processors, cause the one or more processors to:
determine if the second type of data received from the medication delivery device satisfies a minimum dosing data report condition for inclusion into a report, wherein the report comprises metrics based on the first type of data and dosing information based on the second type of data;
generate the report if the received second type of data is determined to be sufficient; and
display a message regarding the report.

### Claim 14 (depends on 13)

The system of claim 13, wherein the minimum dosing data report condition comprises a sufficient amount of second type of data to generate a weekly report.

### Claim 15 (depends on 13)

The system of claim 13, wherein the minimum dosing data report condition comprises a sufficient amount of second type of data to generate a daily report.

### Claim 16 (depends on 13)

The system of claim 13, wherein the second type of data received is determined to satisfy the minimum dosing data report condition if the second type of data received comprises dosing data for at least 1 day.

### Claim 17 (depends on 13)

The system of claim 13, wherein the second type of data received is determined to satisfy the minimum dosing data report condition if the second type of data received comprises dosing data for at least 3 days.

### Claim 18 (depends on 13)

The system of claim 13, wherein the second type of data received is determined to satisfy the minimum dosing data report condition if the second type of data received comprises dosing data for at least 1 week.

### Claim 19 (depends on 13)

The system of claim 13, wherein the message states that the report is available.

### Claim 20 (depends on 13)

The system of claim 13, wherein the message comprises a link to the report.

### Claim at position 17

21-29. (canceled)

### Claim 30

An analyte monitoring system, comprising:
a reader device, comprising:
a display;
wireless communication circuitry configured to receive, from an on-body unit comprising an analyte sensor, a first type of data, and to receive, from a medication delivery device, a second type of data,
wherein the first type of data comprises data indicative of an analyte level of the subject, and
wherein the second type of data comprises medication dosing data; and
one or more processors coupled to a memory, the memory storing instructions that, when executed by the one or more processors, cause the one or more processors to:
determine if a time period elapsed since receipt of the second type of data from the medication delivery device exceeds a threshold value; and
display a message prompting a user to transfer the second type of data.

### Claim 31 (depends on 30)

The system of claim 30, wherein the message comprises a reminder to scan the medication delivery device.

### Claim 32 (depends on 30)

The system of claim 30, wherein the threshold value is 24 hours.

### Claim at position 21

33-46. (canceled)
